Wilder-Smith, A. (2024). The Dengue-in-Dhaka Initiative: Results from a phase 2 trial evaluating the TV005 tetravalent dengue vaccine in Bangladesh. The lancet. Infectious diseases, 24(2), . https://doi.org/10.1007/10.1016/S1473-3099(23)00565-0
Chicago-Zitierstil (17. Ausg.)Wilder-Smith, Annelies. "The Dengue-in-Dhaka Initiative: Results from a Phase 2 Trial Evaluating the TV005 Tetravalent Dengue Vaccine in Bangladesh." The Lancet. Infectious Diseases 24, no. 2 (2024). https://doi.org/10.1007/10.1016/S1473-3099(23)00565-0.
MLA-Zitierstil (9. Ausg.)Wilder-Smith, Annelies. "The Dengue-in-Dhaka Initiative: Results from a Phase 2 Trial Evaluating the TV005 Tetravalent Dengue Vaccine in Bangladesh." The Lancet. Infectious Diseases, vol. 24, no. 2, 2024, https://doi.org/10.1007/10.1016/S1473-3099(23)00565-0.